改良膀胱尿路上皮癌病理淋巴结分期系统的开发与验证
研究基于美国国家癌症数据库(NCDB)12515例和监测、流行病学和最终结果(SEER)数据库5928例肌层浸润性膀胱癌(MIBC)患者,开发并验证了以阳性淋巴结数目为基础的新型病理淋巴结分期系统。结果显示转移淋巴结数目对总死亡率的预测优于淋巴结位置,外部验证区分度良好(乐观校正c指数0.677,95%CI 0.672-0.682),校准良好(5年总死亡率平均绝对预测误差0.011)。
要点
- 转移淋巴结数目连续预测总死亡率,4枚以内效应最明显(HR 1.17,95%CI 1.12-1.22)。
- 新分期切点:0(参照)、1枚(HR 1.57)、2-3枚(HR 2.03)、4-7枚(HR 2.46)、>7枚(HR 3.83)。
- 淋巴结受累位置不是总死亡率的显著预测因素,数目预测优于位置。
核心结论
- 转移淋巴结数目比淋巴结位置更能预测肌层浸润性膀胱癌患者的总死亡率,可能改进病理淋巴结分期。
- 该发现支持对当前膀胱癌分期系统进行改变。
研究设计与样本
- 开发队列为美国国家癌症数据库(NCDB)12515例肌层浸润性膀胱癌患者,验证队列为监测、流行病学和最终结果(SEER)数据库5928例肌层浸润性膀胱癌患者。
- 采用多变量Cox比例风险模型及限制性立方样条评估转移淋巴结数目与总死亡率的关联,通过递归分区分析(RPA)在NCDB中推导新分期系统,并在SEER中评估区分度(Harrel's c指数)与校准度(平均绝对预测误差)。
主要发现
- 死亡风险随转移淋巴结数目增加而持续升高,4枚以内效应最明显(HR 1.17,95%CI 1.12-1.22),超过4枚后减弱(HR 1.03,95%CI 1.02-1.05)。
- 递归分区分析生成以阳性淋巴结数目预测死亡率的新分期系统,切点为0(参照)、1枚(HR 1.57,95%CI 1.46-1.69)、2-3枚(HR 2.03,95%CI 1.88-2.19)、4-7枚(HR 2.46,95%CI 2.25-2.70)、>7枚(HR 3.83,95%CI 3.38-4.33)。
- 淋巴结受累位置不是总死亡率的显著预测因素。
- 外部验证显示新分期系统区分度良好(乐观校正c指数0.677,95%CI 0.672-0.682),校准度良好(5年总死亡率平均绝对预测误差0.011)。
关键数值与推荐
- 新分期系统阳性淋巴结数目切点及对应总死亡率风险比:0枚为参照,1枚HR 1.57(95%CI 1.46-1.69),2-3枚HR 2.03(95%CI 1.88-2.19),4-7枚HR 2.46(95%CI 2.25-2.70),>7枚HR 3.83(95%CI 3.38-4.33)。
- 转移淋巴结数目对总死亡率的影响在4枚以内最明显(HR 1.17,95%CI 1.12-1.22),超过4枚后减弱(HR 1.03,95%CI 1.02-1.05)。
- 外部验证乐观校正c指数0.677(95%CI 0.672-0.682),5年总死亡率平均绝对预测误差0.011。
临床怎么用
- 作者认为转移淋巴结数目比淋巴结位置更能预测肌层浸润性膀胱癌患者的总死亡率,可能改进病理淋巴结分期。
- 作者指出该发现支持对当前膀胱癌分期系统进行改变。
局限性
- 研究结果受限于使用二手数据进行分析与验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current pathological nodal staging for bladder cancer is based on lymph node (LN) location but not on the number of positive LNs. OBJECTIVE: We sought to improve prognostic classification by creating a novel staging system incorporating positive LN burden. DESIGN, SETTING, AND PARTICIPANTS: We sampled 12515 patients with muscle-invasive bladder cancer (MIBC) from the National Cancer Database (NCDB) and 5928 MIBC patients from the Surveillance, Epidemiology, and End Results (SEER) database for our development and validation cohorts, respectively. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Multivariable Cox proportional hazards analysis with restricted cubic splines was used to assess the association between the number of metastatic LNs and overall mortality (OM). A novel staging system was derived by recursive partitioning analysis (RPA) in NCDB and was validated in SEER by assessing discrimination (Harrel's c-index) and calibration (mean absolute prediction error). RESULTS AND LIMITATIONS: Mortality risk increased continuously with more metastatic LNs; the effect was most pronounced up to four LNs (hazard ratio [HR] 1.17, 95% confidence interval [CI] 1.12-1.22) and attenuated beyond four nodes (HR 1.03, 95% CI 1.02-1.05). RPA generated a novel staging system predicting mortality by metastatic nodal number with cutpoints at zero (reference), one (HR 1.57, 95% CI 1.46-1.69), two to three (HR 2.03, 95% CI 1.88-2.19), four to seven (HR 2.46, 95% CI 2.25-2.70), and more than seven (HR 3.83, 95% CI 3.38-4.33) positive LNs. Location of LN involvement was not a significant predictor of OM. In external validation, the novel staging system showed good risk discrimination (optimism corrected c-index 0.677, 95% CI 0.672-0.682) and calibration (mean absolute prediction error 0.011 for 5-yr OM). Results are limited by development and validation using secondary data. CONCLUSIONS: The number of metastatic LNs predicts mortality better than LN location and may improve pathological nodal staging in MIBC. PATIENT SUMMARY: This retrospective study found that the number of metastatic lymph nodes more accurately predicts survival than the location of metastatic lymph nodes in patients with muscle-invasive bladder cancer. This finding argues for change to the current bladder cancer staging system.
引用
- Patel DN, Luu M, Zumsteg ZS, et al. Development and Validation of an Improved Pathological Nodal Staging System for Urothelial Carcinoma of the Bladder. Eur Urol Oncol. 2019. PMID: 31412014. doi:10.1016/j.euo.2018.12.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。